Related Experiment Videos
The ternary microplasmin-staphylokinase-microplasmin complex is a proteinase-cofactor-substrate complex in action
M A Parry1, C Fernandez-Catalan, A Bergner
1Max-Planck Institute of Biochemistry, Department for Structural Research, Martinsried, Germany. parry@biochem.mpg.de
Nature Structural Biology
|October 23, 1998
Summary
This study reveals the crystal structure of microplasmin-staphylokinase bound to microplasmin, detailing how staphylokinase enhances plasminogen activation for clot dissolution. This finding aids in designing better plasminogen activators and inhibitors.
Area of Science:
- Biochemistry
- Structural Biology
- Molecular Medicine
Background:
- Plasmin is a key fibrinolytic enzyme crucial for dissolving blood clots.
- Plasmin also plays roles in cell migration and tissue remodeling.
- Understanding plasmin-enzyme interactions is vital for therapeutic development.
Purpose of the Study:
- To determine the crystal structure of a ternary complex involving microplasmin, staphylokinase, and a second microplasmin molecule.
- To elucidate the mechanism by which staphylokinase acts as a cofactor in plasminogen activation.
- To provide a structural basis for designing improved plasminogen activators and inhibitors.
Main Methods:
- X-ray crystallography was used to determine the structure of the ternary complex at 2.65 A resolution.
- Analysis of the crystal structure focused on the interactions between microplasmin, staphylokinase, and plasminogen.
- Computational reconstruction of the plasminogen activation loop was performed.
Main Results:
- The crystal structure of a productive proteinase-cofactor-macromolecular substrate complex was determined for the first time.
- Staphylokinase, acting as a cofactor, enhances plasminogen presentation to the plasmin active site without altering active-site geometry.
- The structure reveals how the plasminogen activation loop interacts with the plasmin active site prior to cleavage.
Conclusions:
- The staphylokinase cofactor modifies plasmin's subsite specificity, facilitating efficient plasminogen activation.
- The elucidated structure serves as a template for designing novel therapeutic agents targeting the fibrinolytic system.
- This research holds significant potential for developing improved treatments for thrombotic disorders and other conditions involving plasmin activity.